share_log

Healthcare Services Group Analyst Ratings

Healthcare Services Group Analyst Ratings

醫療服務集團分析師評級
Benzinga ·  2023/08/31 20:43
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/31/2023 55.04% Benchmark → $18 Reiterates Buy → Buy
08/01/2023 37.81% RBC Capital → $16 Reiterates Outperform → Outperform
07/27/2023 37.81% RBC Capital $17 → $16 Maintains Outperform
04/28/2023 46.43% Credit Suisse $14 → $17 Maintains Neutral
04/27/2023 46.43% RBC Capital → $17 Reiterates → Outperform
03/24/2023 20.59% Jefferies $8.5 → $14 Upgrades Underperform → Hold
02/21/2023 55.04% Benchmark → $18 Reiterates → Buy
02/17/2023 20.59% Credit Suisse $12 → $14 Maintains Neutral
02/17/2023 46.43% RBC Capital $14 → $17 Upgrades Sector Perform → Outperform
02/13/2023 55.04% Benchmark → $18 Reiterates → Buy
10/20/2022 55.04% Benchmark → $18 Upgrades Hold → Buy
10/20/2022 3.36% Credit Suisse $15 → $12 Maintains Neutral
10/20/2022 20.59% RBC Capital $17 → $14 Maintains Sector Perform
04/21/2022 55.04% Credit Suisse $17 → $18 Maintains Neutral
04/21/2022 72.27% RBC Capital $17 → $20 Maintains Sector Perform
02/10/2022 16.28% Jefferies $19 → $13.5 Downgrades Hold → Underperform
10/22/2021 89.49% Credit Suisse $28 → $22 Maintains Neutral
10/21/2021 72.27% RBC Capital $29 → $20 Maintains Sector Perform
10/20/2021 — William Blair Downgrades Outperform → Market Perform
07/22/2021 149.78% RBC Capital $30 → $29 Maintains Sector Perform
02/11/2021 167.01% Credit Suisse $32 → $31 Maintains Neutral
10/22/2020 123.94% Credit Suisse $31 → $26 Maintains Neutral
07/23/2020 149.78% Baird → $29 Downgrades Outperform → Neutral
07/07/2020 — Northland Capital Markets Downgrades Outperform → Market Perform
07/06/2020 — Benchmark Downgrades Buy → Hold
04/22/2020 132.56% Credit Suisse $32 → $27 Maintains Outperform
04/22/2020 80.88% RBC Capital $26 → $21 Maintains Sector Perform
04/20/2020 141.17% Baird → $28 Upgrades Neutral → Outperform
11/22/2019 123.94% RBC Capital → $26 Initiates Coverage On → Sector Perform
10/23/2019 192.85% Benchmark $37 → $34 Reiterates → Buy
07/24/2019 270.37% Sidoti & Co. $51 → $43 Maintains Buy
07/24/2019 201.46% Credit Suisse $41 → $35 Maintains Outperform
07/12/2019 175.62% Jefferies $40 → $32 Downgrades Buy → Hold
05/01/2019 158.4% Stifel $33 → $30 Maintains Sell
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年08月31日 55.04% 基準 →$18 重申 購買→購買
08/01/2023 37.81% 加拿大皇家銀行資本 →$16 重申 跑贏→跑贏大盤
07/27/2023 37.81% 加拿大皇家銀行資本 $17→$16 維護 跑贏大盤
04/28/2023 46.43% 瑞士信貸 $14→$17 維護 中性
04/27/2023 46.43% 加拿大皇家銀行資本 →$17 重申 →跑贏大盤
03/24/2023 20.59% 傑富瑞 $8.5→$14 升級 表現不佳的→保持
02/21/2023 55.04% 基準 →$18 重申 →購買
02/17/2023 20.59% 瑞士信貸 $12→$14 維護 中性
02/17/2023 46.43% 加拿大皇家銀行資本 $14→$17 升級 行業表現優於→
02/13/2023 55.04% 基準 →$18 重申 →購買
10/20/2022 55.04% 基準 →$18 升級 持有→購買
10/20/2022 3.36% 瑞士信貸 $15→$12 維護 中性
10/20/2022 20.59% 加拿大皇家銀行資本 $17→$14 維護 行業表現
04/21/2022 55.04% 瑞士信貸 $17→$18 維護 中性
04/21/2022 72.27% 加拿大皇家銀行資本 $17→$20 維護 行業表現
02/10/2022 16.28% 傑富瑞 $19→$13.5 評級下調 持有→表現不佳
10/22/2021 89.49% 瑞士信貸 $28→$22 維護 中性
2021/10/21 72.27% 加拿大皇家銀行資本 $29→$20 維護 行業表現
10/20/2021 - 威廉·布萊爾 評級下調 跑贏→市場表現
07/22/2021 149.78% 加拿大皇家銀行資本 $30→$29 維護 行業表現
02/11/2021 167.01% 瑞士信貸 $32→$31 維護 中性
10/22/2020 123.94% 瑞士信貸 $31→$26 維護 中性
07/23/2020 149.78% 貝爾德 →$29 評級下調 跑贏→中性
07/07/2020 - 北國資本市場 評級下調 跑贏→市場表現
07/06/2020 - 基準 評級下調 購買→Hold
04/22/2020 132.56% 瑞士信貸 $32→$27 維護 跑贏大盤
04/22/2020 80.88% 加拿大皇家銀行資本 $26→$21 維護 行業表現
04/20/2020 141.17% 貝爾德 →$28 升級 中性→表現優異
2019年11月22日 123.94% 加拿大皇家銀行資本 →$26 開始承保 →行業表現
2019年10月23日 192.85% 基準 $37→$34 重申 →購買
2019年07月24日 270.37% 西多蒂公司 $51→$43 維護 買
2019年07月24日 201.46% 瑞士信貸 $41→$35 維護 跑贏大盤
2019年07月12日 175.62% 傑富瑞 $40→$32 評級下調 購買→Hold
2019年05月01日 158.4% Stifel $33→$30 維護 賣

What is the target price for Healthcare Services Group (HCSG)?

醫療服務集團(HCSG)的目標價格是多少？

The latest price target for Healthcare Services Group (NASDAQ: HCSG) was reported by Benchmark on August 31, 2023. The analyst firm set a price target for $18.00 expecting HCSG to rise to within 12 months (a possible 55.04% upside). 13 analyst firms have reported ratings in the last year.

醫療服務集團(納斯達克：HCSG)的最新目標價是由Benchmark於2023年8月31日報道的。這家分析公司將目標價定為18.00美元，預計HCSG將在12個月內上漲至55.04%(可能上漲55.04%)。過去一年，有13家分析公司公佈了評級。

What is the most recent analyst rating for Healthcare Services Group (HCSG)?

醫療服務集團(HCSG)的最新分析師評級是多少？

The latest analyst rating for Healthcare Services Group (NASDAQ: HCSG) was provided by Benchmark, and Healthcare Services Group reiterated their buy rating.

醫療保健服務集團(納斯達克：HCSG)的最新分析師評級由Benchmark提供，醫療保健服務集團重申其買入評級。

When is the next analyst rating going to be posted or updated for Healthcare Services Group (HCSG)?

醫療服務集團(HCSG)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Services Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Services Group was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.

分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與醫療保健服務集團的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。醫療服務集團的上一次評級是在2023年8月31日提交的，所以你應該預計下一次評級將在2024年8月31日左右的某個時候公佈。

Is the Analyst Rating Healthcare Services Group (HCSG) correct?

分析師對醫療服務集團(HCSG)的評級正確嗎？

While ratings are subjective and will change, the latest Healthcare Services Group (HCSG) rating was a reiterated with a price target of $0.00 to $18.00. The current price Healthcare Services Group (HCSG) is trading at is $11.61, which is within the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的醫療服務集團(HCSG)評級被重申，目標價在0.00美元至18.00美元之間。醫療保健服務集團(HCSG)目前的交易價格為11.61美元，在分析師的預測範圍內。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論